Literature DB >> 32234021

Accuracy and concordance of measurement methods to assess non-adherence after renal transplantation - a prospective study.

Marietta Lieb1, Tobias Hepp2, Mario Schiffer3, Mirian Opgenoorth3, Yesim Erim4.   

Abstract

BACKGROUND: Non-adherence (NA) to immunosuppressants (IS) among renal transplant recipients (RTRs) is associated with higher risk of allograft rejection, graft loss, and mortality. A precise measurement of NA is indispensable, although its prevalence differs greatly depending on the respective measurement methods. The objective of this study was to assess the accuracy and concordance of different measurement methods of NA in patients after renal transplantation. DESIGN AND METHODS: This was a single-center prospective observational study. At baseline (T0), NA was measured via physicians' estimates (PE), self-reports (SR), and tacrolimus trough level variability (CV%) in 78 RTRs. A Visual Analogue Scale (VAS, 0-100%) was applied both for SR and PE. In addition, we used BAASIS© for SR and a 5-point Likert scale for PE. NA was measured prospectively via electronic monitoring (EM, VAICA©) during a three month period. Meanwhile, all participants received phone calls in a two week interval (T1-T6) during which SRs were given.
RESULTS: Seventy-eight RTRs participated in our study. At t0, NA rates of 6.4%, 28.6%, and 15.4% were found for PE, SR, and CV%, respectively. No correlation was found between these methods. During the study, the percentages of self-reported and electronically monitored adherence remained high, with a minimum mean of 91.2% for the strictest adherence measure (Timing Adherence ±30 min). Our results revealed a moderate to high association between SR and EM. In contrast to PE and CV%, SR significantly predicted electronically monitored adherence. Overall, a decreasing effect of electronically monitored adherence was found for both taking and timing adherence (±2 h, ±30 min) over the course of the study. DISCUSSION: The moderate to high concordance of SR and EM suggests that both methods measure NA equally accurately. SR seems to be a method that can adequately depict electronically monitored NA and may represent a good and economical instrument to assess NA in clinical practice. The increased adherence at the beginning of the study and its subsequent decrease suggests an intervention effect. Surveillance of IS intake via EM with intermittent phone calls could improve adherence on a short-term basis. To establish long-term effects, further research is necessary.

Entities:  

Keywords:  Accuracy; Adherence; Electronic monitoring; IS trough level variability; Measurement methods; Physicians’ estimates; Prospective study; Renal transplant recipients; Self-report

Year:  2020        PMID: 32234021     DOI: 10.1186/s12882-020-01781-1

Source DB:  PubMed          Journal:  BMC Nephrol        ISSN: 1471-2369            Impact factor:   2.388


  4 in total

1.  Pharmacoadherence: An Opportunity for Digital Health to Inform the Third Dimension of Pharmacotherapy for Diabetes.

Authors:  David C Klonoff; Jennifer Y Zhang; Trisha Shang; Chhavi Mehta; David Kerr
Journal:  J Diabetes Sci Technol       Date:  2020-12-08

2.  Optimization of Electronically Monitored Non-Adherence in Highly Adherent Renal Transplant Recipients by Reducing the Dosing Frequency - A Prospective Single-Center Observational Study.

Authors:  Marietta Lieb; Mario Schiffer; Yesim Erim
Journal:  Patient Prefer Adherence       Date:  2020-08-05       Impact factor: 2.711

3.  Prospective single-centre clinical observational study on electronically monitored medication non-adherence, its psychosocial risk factors and lifestyle behaviours after heart transplantation: a study protocol.

Authors:  Marietta Lieb; Michael Weyand; Margot Seidl; Yesim Erim
Journal:  BMJ Open       Date:  2020-10-07       Impact factor: 2.692

4.  Comparing medication adherence using a smartphone application and electronic monitoring among patients with acute coronary syndrome.

Authors:  Nicholas A Giordano; Kathryn A Riman; Rachel French; Marguerite Daus; Alisa J Stephens-Shields; Stephen E Kimmel; Barbara Riegel
Journal:  Appl Nurs Res       Date:  2021-05-24       Impact factor: 1.847

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.